This inventor holds 1 USPTO granted patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Satoshi Takeda: Innovator in Genetic Research
Introduction
Satoshi Takeda is a prominent inventor based in Tokushima, Japan. He is known for his significant contributions to genetic research, particularly in the field of transcription regulation. His work has implications for understanding hereditary diseases, including cancer.
Latest Patents
Satoshi Takeda holds a patent for the hTFIIIA gene. This patent describes an isolated hTFIIIA gene that has a nucleotide sequence coding for the amino acid sequence of SEQ ID NO:1. Specifically, it includes the hTFIIIA gene with the nucleotide sequence of SEQ ID NO:2. The gene can be utilized to express a corresponding hTFIIIA protein, which serves as a transcription regulating factor. This innovation is useful in diagnosing hereditary diseases and analyzing the mechanisms of transcriptional control.
Career Highlights
Satoshi Takeda is affiliated with Otsuka Pharmaceutical Company, Limited, where he continues to advance his research in genetics. His work has garnered attention for its potential applications in medical diagnostics and therapeutic development.
Collaborations
He has collaborated with notable colleagues, including Tsutomu Fujiwara and Yoshikazu Shimada, to further enhance the impact of his research.
Conclusion
Satoshi Takeda's contributions to genetic research, particularly through his patent on the hTFIIIA gene, highlight his role as an innovator in the field. His work continues to pave the way for advancements in understanding and treating hereditary diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile